Innovations in Next-Generation Endocrine Therapies for HR+/HER2- Breast Cancer Breast Cancer Survival Rates
Survival rates for breast cancer depend on factors such as the stage at diagnosis, tumor subtype, and available treatments. The five-year survival rate for stage 2 breast cancer is around 90%, with slightly lower rates for stage 2B. Continuous advancements in HR+ HER2- breast cancer treatment have significantly improved outcomes, underscoring the importance of...
0 Поделились
27 Просмотров